查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1922525

日本再生醫學市場報告：按類型、應用、最終用戶和地區分類（2026-2034年）

Japan Regenerative Medicine Market Report by Type, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

日本再生醫學市場在2025年達到94億美元。展望未來，IMARC Group預測，到2034年，該市場將達到235億美元，2026年至2034年的複合年成長率為10.67%。推動市場成長的因素有很多，包括人們對移植排斥反應的日益關注、對使用再生醫學進行整形外科治療的需求不斷成長、對牙科再生醫學的關注度提高以及用於創傷治療的藥物使用量不斷增加。

再生醫學是生物醫學領域一個極具發展前景的分支，專注於修復受損組織和器官。它涉及將實驗室培養的幹細胞安全地植入體內，以促進包括骨骼、軟骨、血管和主要器官在內的各種身體組成的再生。這種綜合方法涵蓋了多種基於細胞和非細胞的再生療法，並融合了免疫調節和組織工程等技術。除了在組織修復方面的作用外，再生醫學在治療阿茲海默症、帕金森氏症、心血管疾病、骨質疏鬆症和脊髓損傷等疑難雜症方面也展現出巨大的潛力。不斷深入的研究為創新治療方法帶來了樂觀的前景，這些療法有望顯著改善患者的生活品質和醫療效果。

日本再生醫學市場的發展趨勢：

日本再生醫學市場正經歷顯著成長，這主要歸因於人口老化的加劇。人口老化與糖尿病、心臟病和骨關節炎等慢性疾病發病率的上升密切相關，大大推動了市場擴張。此外，幹細胞療法和基因工程研究的日益普及也推動了再生醫學領域的創新。幹細胞和其他細胞療法在組織再生和修復方面的廣泛應用也進一步促進了市場發展。尤其值得一提的是，政府對再生醫學研發的資金和監管支持，支撐了市場的強勁成長。生物技術的不斷進步使得更精準、更有效的再生療法得以開發，進一步促進了市場成長。此外，患者對再生醫學治療方法的認知度不斷提高，也成為市場擴張的另一個催化劑。癌症發生率的上升以及對更有效率、更人性化治療方法方案的探索，推動了癌症治療領域對再生醫學的需求，並在市場成長中發揮關鍵作用。

本報告解答的關鍵問題

  • 1. 日本再生醫學市場規模有多大？
  • 2. 日本再生醫學市場的前景如何？
  • 3.哪些因素正在推動日本再生醫學市場的成長？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 調查方法

第3章執行摘要

第4章：日本再生醫學市場－引言

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章 日本再生醫學市場概述

  • 過去和當前的市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章：日本再生醫學市場－按類型細分

  • 幹細胞療法
  • 生物材料
  • 組織工程
  • 其他

第7章 日本再生醫學市場－依應用領域細分

  • 骨移植替代物
  • 骨骼和關節疾病
  • 皮膚科
  • 循環系統
  • 中樞神經系統
  • 其他

第8章：日本再生醫學市場－依最終用戶細分

  • 醫院
  • 專科診所
  • 其他

第9章：日本再生醫學市場：依地區分類

  • 關東地區
  • 關西、近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第10章：日本再生醫學市場：競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第11章主要企業概況

第12章：日本再生醫學市場：產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第13章附錄

簡介目錄
Product Code: SR112026A19898

Japan regenerative medicine market size reached USD 9.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 23.5 Billion by 2034, exhibiting a growth rate (CAGR) of 10.67% during 2026-2034. The market is being driven by a range of factors, including heightened worries about transplant rejection, a greater need for regenerative orthopedic treatments, an increasing focus on dental regeneration, and the growing utilization of medicine for wound healing.

Access the full market insights report Request Sample

Regenerative medicine is an auspicious field within biomedical science that focuses on repairing damaged tissues and organs. It involves the use of laboratory-cultivated stem cells, which are safely transplanted into the body to encourage the regeneration of various bodily components such as bones, cartilage, blood vessels, and essential organs. This comprehensive approach includes a variety of regenerative therapies, both cellular and acellular, incorporating techniques like immunomodulation and tissue engineering. Apart from its role in tissue repair, regenerative medicine shows great promise in addressing persistent conditions such as Alzheimer's, Parkinson's, cardiovascular diseases (CVDs), osteoporosis, and spinal cord injuries. As research progresses, it presents an optimistic outlook for revolutionary treatments that have the potential to significantly enhance patients' quality of life and overall healthcare outcomes.

JAPAN REGENERATIVE MEDICINE MARKET TRENDS:

The Japan regenerative medicine market is experiencing substantial growth primarily due to the expanding elderly population. This demographic shift correlates with a heightened incidence of chronic ailments like diabetes, heart disease, and osteoarthritis, thus significantly contributing to the market's expansion. Moreover, the increasing focus on stem cell therapies and genetic engineering research is fostering innovation within the realm of regenerative medicine. The market is further stimulated by the growing utilization of stem cells and other cell-based therapies for the purpose of tissue regeneration and repair. Notably, the positive trajectory of the market is sustained by the allocation of funding and regulatory support for the advancement of regenerative medicine research and development. The continual advancements in biotechnology are facilitating the development of more precise and efficacious regenerative therapies, thereby bolstering the market's growth. Additionally, the rising awareness among patients regarding the availability of regenerative treatment options is serving as an additional catalyst for market expansion. The increasing occurrence of cancer and the quest for treatments that are both more efficient and accommodating for patients are driving the need for regenerative medicine in cancer treatment, playing a substantial role in the growth of the market.

JAPAN REGENERATIVE MEDICINE MARKET SEGMENTATION:

Type Insights:

  • To get detailed segment analysis of this market Request Sample
  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering
  • Others
  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering
  • Others

Application Insights:

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Dermatology
  • Cardiovascular
  • Central Nervous System
  • Others
  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Dermatology
  • Cardiovascular
  • Central Nervous System
  • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Others
  • Hospitals
  • Specialty Clinics
  • Others

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the regenerative medicine market in Japan?

2. What is the forecast for the regenerative medicine market in Japan?

3. What factors are driving the growth of the Japan regenerative medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Regenerative Medicine Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Regenerative Medicine Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Regenerative Medicine Market - Breakup by Type

  • 6.1 Stem Cell Therapy
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Biomaterial
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Tissue Engineering
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Others
    • 6.4.1 Historical and Current Market Trends (2020-2025)
    • 6.4.2 Market Forecast (2026-2034)

7 Japan Regenerative Medicine Market - Breakup by Application

  • 7.1 Bone Graft Substitutes
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Osteoarticular Diseases
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Dermatology
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Cardiovascular
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Central Nervous System
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Others
    • 7.6.1 Historical and Current Market Trends (2020-2025)
    • 7.6.2 Market Forecast (2026-2034)

8 Japan Regenerative Medicine Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Specialty Clinics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Others
    • 8.3.1 Historical and Current Market Trends (2020-2025)
    • 8.3.2 Market Forecast (2026-2034)

9 Japan Regenerative Medicine Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Type
    • 9.1.4 Market Breakup by Application
    • 9.1.5 Market Breakup by End User
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Type
    • 9.2.4 Market Breakup by Application
    • 9.2.5 Market Breakup by End User
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Type
    • 9.3.4 Market Breakup by Application
    • 9.3.5 Market Breakup by End User
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Type
    • 9.4.4 Market Breakup by Application
    • 9.4.5 Market Breakup by End User
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Type
    • 9.5.4 Market Breakup by Application
    • 9.5.5 Market Breakup by End User
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Type
    • 9.6.4 Market Breakup by Application
    • 9.6.5 Market Breakup by End User
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Type
    • 9.7.4 Market Breakup by Application
    • 9.7.5 Market Breakup by End User
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Type
    • 9.8.4 Market Breakup by Application
    • 9.8.5 Market Breakup by End User
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Regenerative Medicine Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Regenerative Medicine Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix